Movatterモバイル変換

[0]ホーム
URL:

Skip to main content
NCBI home page
Search in PMCSearch
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health.
Learn more:PMC Disclaimer | PMC Copyright Notice
Protein Science : A Publication of the Protein Society logo

Carbocations in the synthesis of prostaglandins by the cyclooxygenase of PGH synthase? A radical departure!

A M Dean1,F M Dean1
1Biological Process Technology Institute and Department of Ecology, Evolution and Behavior, University of Minnesota, St. Paul 55108-6106, USA.
PMCID: PMC2144324  PMID:10338019

Abstract

Evidence already available is used to demonstrate that although prostaglandin G/H synthase hydroxylates arachidonic acid through radical intermediates, it effects cyclizations through a carbocation center at C-10. This is produced following migration of H to the initial radical at C-13 and a 1epsilon oxidation. Under orbital symmetry control, the cyclizations can give only the ring size and trans stereochemistry actually observed. After cyclization, the H-shift reverses to take the sequence back into current radical theory for hydroxylation at C-15. Thus 10,10-difluoroarachidonic acid cannot be cyclized, although it can be hydroxylated. Acetylation of Ser516 in the isoform synthase-2 is considered to oppose carbocation formation and/or H-migration and so prevent cyclizations while permitting hydroxylations; the associated inversion of chirality at C-15 can then readily be accommodated without the change in conformation required by other schemes. Suicide inhibition occurs when carbocations form stable bonds upon (thermal) contact with adjacent heteroatoms, etc. Because the cyclooxygenase and peroxidase functions operate simultaneously through the same heme, phenol acts as reducing cosubstrate for the cyclooxygenase, thus enabling it to promote PGG2 production and protect the enzyme from oxidative destruction.

Full Text

The Full Text of this article is available as aPDF (231.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andberg M. B., Hamberg M., Haeggström J. Z. Mutation of tyrosine 383 in leukotriene A4 hydrolase allows conversion of leukotriene A4 into 5S,6S-dihydroxy-7,9-trans-11,14-cis-eicosatetraenoic acid. Implications for the epoxide hydrolase mechanism. J Biol Chem. 1997 Sep 12;272(37):23057–23063. doi: 10.1074/jbc.272.37.23057. [DOI] [PubMed] [Google Scholar]
  2. Bild G. S., Bhat S. G., Ramadoss C. S., Axelrod B. Biosynthesis of a prostaglandin by a plant enzyme. J Biol Chem. 1978 Jan 10;253(1):21–23. [PubMed] [Google Scholar]
  3. Clissold D., Thickitt C. Recent eicosanoid chemistry. Nat Prod Rep. 1994 Dec;11(6):621–637. doi: 10.1039/np9941100621. [DOI] [PubMed] [Google Scholar]
  4. Dalton H., Wilkins P. The iron form of methane mono-oxygenase and its mode of action. Biochem Soc Trans. 1997 Feb;25(1):69–74. doi: 10.1042/bst0250069. [DOI] [PubMed] [Google Scholar]
  5. DeGray J. A., Lassmann G., Curtis J. F., Kennedy T. A., Marnett L. J., Eling T. E., Mason R. P. Spectral analysis of the protein-derived tyrosyl radicals from prostaglandin H synthase. J Biol Chem. 1992 Nov 25;267(33):23583–23588. [PubMed] [Google Scholar]
  6. DeWitt D. L., el-Harith E. A., Kraemer S. A., Andrews M. J., Yao E. F., Armstrong R. L., Smith W. L. The aspirin and heme-binding sites of ovine and murine prostaglandin endoperoxide synthases. J Biol Chem. 1990 Mar 25;265(9):5192–5198. [PubMed] [Google Scholar]
  7. Dhe-Paganon S., Magrath J., Abeles R. H. Mechanism of mevalonate pyrophosphate decarboxylase: evidence for a carbocationic transition state. Biochemistry. 1994 Nov 15;33(45):13355–13362. doi: 10.1021/bi00249a023. [DOI] [PubMed] [Google Scholar]
  8. Dietz R., Nastainczyk W., Ruf H. H. Higher oxidation states of prostaglandin H synthase. Rapid electronic spectroscopy detected two spectral intermediates during the peroxidase reaction with prostaglandin G2. Eur J Biochem. 1988 Jan 15;171(1-2):321–328. doi: 10.1111/j.1432-1033.1988.tb13793.x. [DOI] [PubMed] [Google Scholar]
  9. Ding X. X., Coon M. J. Cytochrome P-450-dependent formation of ethylene from N-nitrosoethylamines. Drug Metab Dispos. 1988 Mar-Apr;16(2):265–269. [PubMed] [Google Scholar]
  10. Egan R. W., Humes J. L., Kuehl F. A., Jr Differential effects of prostaglandin synthetase stimulators on inhibition of cyclooxygenase. Biochemistry. 1978 May 30;17(11):2230–2234. doi: 10.1021/bi00604a033. [DOI] [PubMed] [Google Scholar]
  11. Egan R. W., Paxton J., Kuehl F. A., Jr Mechanism for irreversible self-deactivation of prostaglandin synthetase. J Biol Chem. 1976 Dec 10;251(23):7329–7335. [PubMed] [Google Scholar]
  12. Eling T. E., Thompson D. C., Foureman G. L., Curtis J. F., Hughes M. F. Prostaglandin H synthase and xenobiotic oxidation. Annu Rev Pharmacol Toxicol. 1990;30:1–45. doi: 10.1146/annurev.pa.30.040190.000245. [DOI] [PubMed] [Google Scholar]
  13. Goodwin D. C., Gunther M. R., Hsi L. C., Crews B. C., Eling T. E., Mason R. P., Marnett L. J. Nitric oxide trapping of tyrosyl radicals generated during prostaglandin endoperoxide synthase turnover. Detection of the radical derivative of tyrosine 385. J Biol Chem. 1998 Apr 10;273(15):8903–8909. doi: 10.1074/jbc.273.15.8903. [DOI] [PubMed] [Google Scholar]
  14. Green J., Dalton H. Substrate specificity of soluble methane monooxygenase. Mechanistic implications. J Biol Chem. 1989 Oct 25;264(30):17698–17703. [PubMed] [Google Scholar]
  15. Guo Q., Chang S., Diekman L., Xiao G., Kulmacz R. J. Comparison of prostaglandin H synthase isoform structures using limited proteolytic digestion. Arch Biochem Biophys. 1997 Aug 1;344(1):150–158. doi: 10.1006/abbi.1997.0192. [DOI] [PubMed] [Google Scholar]
  16. Hamberg M., Samuelsson B. On the mechanism of the biosynthesis of prostaglandins E-1 and F-1-alpha. J Biol Chem. 1967 Nov 25;242(22):5336–5343. [PubMed] [Google Scholar]
  17. Hamberg M. Stereochemistry of oxygenation of linoleic acid catalyzed by prostaglandin-endoperoxide H synthase-2. Arch Biochem Biophys. 1998 Jan 15;349(2):376–380. doi: 10.1006/abbi.1997.0443. [DOI] [PubMed] [Google Scholar]
  18. Hemler M. E., Cook H. W., Lands W. E. Prostaglandin biosynthesis can be triggered by lipid peroxides. Arch Biochem Biophys. 1979 Apr 1;193(2):340–345. doi: 10.1016/0003-9861(79)90038-9. [DOI] [PubMed] [Google Scholar]
  19. Hemler M. E., Crawford C. G., Lands W. E. Lipoxygenation activity of purified prostaglandin-forming cyclooxygenase. Biochemistry. 1978 May 2;17(9):1772–1779. doi: 10.1021/bi00602a031. [DOI] [PubMed] [Google Scholar]
  20. Hemler M. E., Lands W. E. Evidence for a peroxide-initiated free radical mechanism of prostaglandin biosynthesis. J Biol Chem. 1980 Jul 10;255(13):6253–6261. [PubMed] [Google Scholar]
  21. Hsi L. C., Hoganson C. W., Babcock G. T., Garavito R. M., Smith W. L. An examination of the source of the tyrosyl radical in ovine prostaglandin endoperoxide synthase-1. Biochem Biophys Res Commun. 1995 Feb 15;207(2):652–660. doi: 10.1006/bbrc.1995.1237. [DOI] [PubMed] [Google Scholar]
  22. Jourdan K. B., Mitchell J. A., Evans T. W. Release of isoprostanes by human pulmonary artery in organ culture: a cyclo-oxygenase and nitric oxide dependent pathway. Biochem Biophys Res Commun. 1997 Apr 28;233(3):668–672. doi: 10.1006/bbrc.1997.6523. [DOI] [PubMed] [Google Scholar]
  23. Karthein R., Dietz R., Nastainczyk W., Ruf H. H. Higher oxidation states of prostaglandin H synthase. EPR study of a transient tyrosyl radical in the enzyme during the peroxidase reaction. Eur J Biochem. 1988 Jan 15;171(1-2):313–320. doi: 10.1111/j.1432-1033.1988.tb13792.x. [DOI] [PubMed] [Google Scholar]
  24. Kulmacz R. J., Ren Y., Tsai A. L., Palmer G. Prostaglandin H synthase: spectroscopic studies of the interaction with hydroperoxides and with indomethacin. Biochemistry. 1990 Sep 18;29(37):8760–8771. doi: 10.1021/bi00489a037. [DOI] [PubMed] [Google Scholar]
  25. Kurumbail R. G., Stevens A. M., Gierse J. K., McDonald J. J., Stegeman R. A., Pak J. Y., Gildehaus D., Miyashiro J. M., Penning T. D., Seibert K. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature. 1996 Dec 19;384(6610):644–648. doi: 10.1038/384644a0. [DOI] [PubMed] [Google Scholar]
  26. Lambeir A. M., Markey C. M., Dunford H. B., Marnett L. J. Spectral properties of the higher oxidation states of prostaglandin H synthase. J Biol Chem. 1985 Dec 5;260(28):14894–14896. [PubMed] [Google Scholar]
  27. Landino L. M., Crews B. C., Timmons M. D., Morrow J. D., Marnett L. J. Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15069–15074. doi: 10.1073/pnas.93.26.15069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Lanzo C. A., Beechem J. M., Talley J., Marnett L. J. Investigation of the binding of isoform-selective inhibitors to prostaglandin endoperoxide synthases using fluorescence spectroscopy. Biochemistry. 1998 Jan 6;37(1):217–226. doi: 10.1021/bi971691n. [DOI] [PubMed] [Google Scholar]
  29. Lassmann G., Odenwaller R., Curtis J. F., DeGray J. A., Mason R. P., Marnett L. J., Eling T. E. Electron spin resonance investigation of tyrosyl radicals of prostaglandin H synthase. Relation to enzyme catalysis. J Biol Chem. 1991 Oct 25;266(30):20045–20055. [PubMed] [Google Scholar]
  30. Lecomte M., Laneuville O., Ji C., DeWitt D. L., Smith W. L. Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. J Biol Chem. 1994 May 6;269(18):13207–13215. [PubMed] [Google Scholar]
  31. Lecomte M., Lecocq R., Dumont J. E., Boeynaems J. M. Covalent binding of arachidonic acid metabolites to human platelet proteins. Identification of prostaglandin H synthase as one of the modified substrates. J Biol Chem. 1990 Mar 25;265(9):5178–5187. [PubMed] [Google Scholar]
  32. Lipscomb J. D. Biochemistry of the soluble methane monooxygenase. Annu Rev Microbiol. 1994;48:371–399. doi: 10.1146/annurev.mi.48.100194.002103. [DOI] [PubMed] [Google Scholar]
  33. Loll P. J., Picot D., Ekabo O., Garavito R. M. Synthesis and use of iodinated nonsteroidal antiinflammatory drug analogs as crystallographic probes of the prostaglandin H2 synthase cyclooxygenase active site. Biochemistry. 1996 Jun 11;35(23):7330–7340. doi: 10.1021/bi952776w. [DOI] [PubMed] [Google Scholar]
  34. Loll P. J., Picot D., Garavito R. M. The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase. Nat Struct Biol. 1995 Aug;2(8):637–643. doi: 10.1038/nsb0895-637. [DOI] [PubMed] [Google Scholar]
  35. Luong C., Miller A., Barnett J., Chow J., Ramesha C., Browner M. F. Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2. Nat Struct Biol. 1996 Nov;3(11):927–933. doi: 10.1038/nsb1196-927. [DOI] [PubMed] [Google Scholar]
  36. Mancini J. A., O'Neill G. P., Bayly C., Vickers P. J. Mutation of serine-516 in human prostaglandin G/H synthase-2 to methionine or aspirin acetylation of this residue stimulates 15-R-HETE synthesis. FEBS Lett. 1994 Mar 28;342(1):33–37. doi: 10.1016/0014-5793(94)80579-2. [DOI] [PubMed] [Google Scholar]
  37. Markey C. M., Alward A., Weller P. E., Marnett L. J. Quantitative studies of hydroperoxide reduction by prostaglandin H synthase. Reducing substrate specificity and the relationship of peroxidase to cyclooxygenase activities. J Biol Chem. 1987 May 5;262(13):6266–6279. [PubMed] [Google Scholar]
  38. Marnett L. J., Chen Y. N., Maddipati K. R., Plé P., Labèque R. Functional differentiation of cyclooxygenase and peroxidase activities of prostaglandin synthase by trypsin treatment. Possible location of a prosthetic heme binding site. J Biol Chem. 1988 Nov 15;263(32):16532–16535. [PubMed] [Google Scholar]
  39. Marshall P. J., Kulmacz R. J., Lands W. E. Constraints on prostaglandin biosynthesis in tissues. J Biol Chem. 1987 Mar 15;262(8):3510–3517. [PubMed] [Google Scholar]
  40. Marshall P. J., Kulmacz R. J. Prostaglandin H synthase: distinct binding sites for cyclooxygenase and peroxidase substrates. Arch Biochem Biophys. 1988 Oct;266(1):162–170. doi: 10.1016/0003-9861(88)90246-9. [DOI] [PubMed] [Google Scholar]
  41. Michon T., Chenu M., Kellershon N., Desmadril M., Guéguen J. Horseradish peroxidase oxidation of tyrosine-containing peptides and their subsequent polymerization: a kinetic study. Biochemistry. 1997 Jul 15;36(28):8504–8513. doi: 10.1021/bi963168z. [DOI] [PubMed] [Google Scholar]
  42. Morrow J. D., Roberts L. J., 2nd The isoprostanes. Current knowledge and directions for future research. Biochem Pharmacol. 1996 Jan 12;51(1):1–9. doi: 10.1016/0006-2952(95)02072-1. [DOI] [PubMed] [Google Scholar]
  43. Mueller M. J., Blomster M., Oppermann U. C., Jörnvall H., Samuelsson B., Haeggström J. Z. Leukotriene A4 hydrolase: protection from mechanism-based inactivation by mutation of tyrosine-378. Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5931–5935. doi: 10.1073/pnas.93.12.5931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Mueller M. J., Wetterholm A., Blomster M., Jörnvall H., Samuelsson B., Haeggström J. Z. Leukotriene A4 hydrolase: mapping of a henicosapeptide involved in mechanism-based inactivation. Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8383–8387. doi: 10.1073/pnas.92.18.8383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Nastainczyk W., Schuhn D., Ullrich V. Spectral intermediates of prostaglandin hydroperoxidase. Eur J Biochem. 1984 Oct 15;144(2):381–385. doi: 10.1111/j.1432-1033.1984.tb08475.x. [DOI] [PubMed] [Google Scholar]
  46. O'Neill G. P., Mancini J. A., Kargman S., Yergey J., Kwan M. Y., Falgueyret J. P., Abramovitz M., Kennedy B. P., Ouellet M., Cromlish W. Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid. Mol Pharmacol. 1994 Feb;45(2):245–254. [PubMed] [Google Scholar]
  47. Odenwaller R., Maddipati K. R., Marnett L. J. Detection of a higher oxidation state of manganese-prostaglandin endoperoxide synthase. J Biol Chem. 1992 Jul 15;267(20):13863–13869. [PubMed] [Google Scholar]
  48. Picot D., Loll P. J., Garavito R. M. The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1. Nature. 1994 Jan 20;367(6460):243–249. doi: 10.1038/367243a0. [DOI] [PubMed] [Google Scholar]
  49. Plé P., Marnett L. J. Alkylaryl sulfides as peroxidase reducing substrates for prostaglandin H synthase. Probes for the reactivity and environment of the ferryl-oxo complex. J Biol Chem. 1989 Aug 25;264(24):13983–13993. [PubMed] [Google Scholar]
  50. Ruzicka F., Huang D. S., Donnelly M. I., Frey P. A. Methane monooxygenase catalyzed oxygenation of 1,1-dimethylcyclopropane. Evidence for radical and carbocationic intermediates. Biochemistry. 1990 Feb 20;29(7):1696–1700. doi: 10.1021/bi00459a005. [DOI] [PubMed] [Google Scholar]
  51. Schreiber J., Eling T. E., Mason R. P. The oxidation of arachidonic acid by the cyclooxygenase activity of purified prostaglandin H synthase: spin trapping of a carbon-centered free radical intermediate. Arch Biochem Biophys. 1986 Aug 15;249(1):126–136. doi: 10.1016/0003-9861(86)90567-9. [DOI] [PubMed] [Google Scholar]
  52. Shimokawa T., Kulmacz R. J., DeWitt D. L., Smith W. L. Tyrosine 385 of prostaglandin endoperoxide synthase is required for cyclooxygenase catalysis. J Biol Chem. 1990 Nov 25;265(33):20073–20076. [PubMed] [Google Scholar]
  53. Smith W. L., Eling T. E., Kulmacz R. J., Marnett L. J., Tsai A. Tyrosyl radicals and their role in hydroperoxide-dependent activation and inactivation of prostaglandin endoperoxide synthase. Biochemistry. 1992 Jan 14;31(1):3–7. doi: 10.1021/bi00116a001. [DOI] [PubMed] [Google Scholar]
  54. Smith W. L., Marnett L. J. Prostaglandin endoperoxide synthase: structure and catalysis. Biochim Biophys Acta. 1991 Apr 24;1083(1):1–17. doi: 10.1016/0005-2760(91)90119-3. [DOI] [PubMed] [Google Scholar]
  55. Strieder S., Schaible K., Scherer H. J., Dietz R., Ruf H. H. Prostaglandin endoperoxide synthase substituted with manganese protoporphyrin IX. Formation of a higher oxidation state and its relation to cyclooxygenase reaction. J Biol Chem. 1992 Jul 15;267(20):13870–13878. [PubMed] [Google Scholar]
  56. Tang M. S., Copeland R. A., Penning T. M. Detection of an Fe2+-protoporphyrin-IX intermediate during aspirin-treated prostaglandin H2 synthase II catalysis of arachidonic acid to 15-HETE. Biochemistry. 1997 Jun 17;36(24):7527–7534. doi: 10.1021/bi962750k. [DOI] [PubMed] [Google Scholar]
  57. Tsai A. l., Palmer G., Xiao G., Swinney D. C., Kulmacz R. J. Structural characterization of arachidonyl radicals formed by prostaglandin H synthase-2 and prostaglandin H synthase-1 reconstituted with mangano protoporphyrin IX. J Biol Chem. 1998 Feb 13;273(7):3888–3894. doi: 10.1074/jbc.273.7.3888. [DOI] [PubMed] [Google Scholar]
  58. Tsai A. l., Wei C., Baek H. K., Kulmacz R. J., Van Wart H. E. Comparison of peroxidase reaction mechanisms of prostaglandin H synthase-1 containing heme and mangano protoporphyrin IX. J Biol Chem. 1997 Apr 4;272(14):8885–8894. doi: 10.1074/jbc.272.14.8885. [DOI] [PubMed] [Google Scholar]
  59. Vannelli T., Hooper A. B. NIH shift in the hydroxylation of aromatic compounds by the ammonia-oxidizing bacterium Nitrosomonas europaea. Evidence against an arene oxide intermediate. Biochemistry. 1995 Sep 19;34(37):11743–11749. doi: 10.1021/bi00037a011. [DOI] [PubMed] [Google Scholar]
  60. Vaz A. D., McGinnity D. F., Coon M. J. Epoxidation of olefins by cytochrome P450: evidence from site-specific mutagenesis for hydroperoxo-iron as an electrophilic oxidant. Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3555–3560. doi: 10.1073/pnas.95.7.3555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Wong E., Bayly C., Waterman H. L., Riendeau D., Mancini J. A. Conversion of prostaglandin G/H synthase-1 into an enzyme sensitive to PGHS-2-selective inhibitors by a double His513 --> Arg and Ile523 --> val mutation. J Biol Chem. 1997 Apr 4;272(14):9280–9286. doi: 10.1074/jbc.272.14.9280. [DOI] [PubMed] [Google Scholar]
  62. Xiao G., Tsai A. L., Palmer G., Boyar W. C., Marshall P. J., Kulmacz R. J. Analysis of hydroperoxide-induced tyrosyl radicals and lipoxygenase activity in aspirin-treated human prostaglandin H synthase-2. Biochemistry. 1997 Feb 18;36(7):1836–1845. doi: 10.1021/bi962476u. [DOI] [PubMed] [Google Scholar]
  63. Yamamoto S. "Enzymatic" lipid peroxidation: reactions of mammalian lipoxygenases. Free Radic Biol Med. 1991;10(2):149–159. doi: 10.1016/0891-5849(91)90008-q. [DOI] [PubMed] [Google Scholar]

Articles from Protein Science : A Publication of the Protein Society are provided here courtesy ofThe Protein Society

ACTIONS

RESOURCES

[8]ページ先頭
©2009-2025 Movatter.jp